Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Refractory Crohn's Disease Lesions by Local Injection of Mesenchymal Stem Cells
2024-514033-37-00Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Oct 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of allogeneic bone marrow-derived mesenchymal stromal cells in Crohn's disease (3 cohorts), sponsored by Centre Hospitalier Universitaire de Liège. Started Oct 2024; status: completed.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2024-514033-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514033-37-00.